CSIMarket
 


Mateon Therapeutics Inc  (OXGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare


Mateon Therapeutics Inc's EBITDA Margin by quarter

Trends, Rankings, Statistics



OXGN EBITDA Margin (Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
Y / Y Revenue Change - - - - -
Y / Y EBITDA Change - - - - -
EBITDA Margin 67.54 % - - - -
EBITDA Margin Total Ranking # 291 # # # #
Seq. Revenue Change 310.73 % - - - -
Seq. EBITDA Change - - - - -


Commenting Second Quarter 2020 EBITDA Margin
Mateon Therapeutics Inc achieved EBITDA of $1 millions compare to Operating Loss of $-2.27 millions recorded in previous quarter. Revenue increased by 310.73 % Company achieved below average EBITDA Margin with 67.54 %.

Observing second quarter 2020 results within Biotechnology & Drugs industry 4 other companies have achieved higher EBITDA Margin. While EBITDA Margin overall ranking has deteriorated compare to previous quarter from to 291.
Learn about Operating Margin
OXGN's EBITDA Margin second quarter 2020 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 5
Healthcare Sector # 23
Overall # 291

EBITDA Margin Statistics
High Average Low
67.54 % 67.54 % 67.54 %
(Jun 30 2020)  



Financial Statements
Mateon Therapeutics Inc's (Jun 30 2020) EBITDA $ 1 OXGN's Income Statement
Mateon Therapeutics Inc's (Jun 30 2019) EBITDA $ -1 Quarterly OXGN's Growth
OXGN's Profits by Division See OXGN's Profits by Segment

Other EBITDA Margin Profitability Ratios
OXGN's Cumulative EBITDA Margin
Biotechnology & Drugs Industry EBITDA Margin Trends and Statistics
Healthcare Sector EBITDA Margin Statistics
EBITDA Margin Profitability Trends for overall market
OXGN's EBITDA Margin Profitability versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking EBITDA Margin
Lowest Ranking EBITDA Margin
EBITDA Margin Profit Margin for OXGN's Competitors
EBITDA Margin Profit Margin for Mateon Therapeutics Inc's Suppliers
EBITDA Margin Profit Margin for OXGN's Customers

You may also want to know
OXGN's Annual Growth Rates OXGN's Profitability Ratios OXGN's Asset Turnover Ratio OXGN's Dividend Growth
OXGN's Roe OXGN's Valuation Ratios OXGN's Financial Strength Ratios OXGN's EBITDA Growth
OXGN's Roa OXGN's Inventory Turnover Ratio OXGN's Growth Rates OXGN's Dividend Comparisons


Companies with similar EBITDA Margin in the quarter ending Jun 30 2020, within Biotechnology & Drugs Industry EBITDA MarginJun 30 2020 MRQ EBITDAJun 30 2020 MRQ Revenue
Royalty Pharma Plc  124.51 %$ 636.165 $ 510.932 
Mateon Therapeutics Inc  67.54 %$ 0.946 $ 1.400 
Aerpio Pharmaceuticals Inc   62.07 %$ 9.311 $ 15.000 
Biogen Inc   58.41 %$ 2,150.400 $ 3,681.600 
Bio techne Corp  57.85 %$ 101.712 $ 175.834 
Coherus Biosciences inc   49.66 %$ 67.377 $ 135.674 
Quidel Corp  47.47 %$ 95.765 $ 201.754 
Meridian Bioscience Inc  46.06 %$ 39.054 $ 84.797 
Emergent Biosolutions Inc   39.65 %$ 156.500 $ 394.700 
Quest Patent Research Corp  37.15 %$ 0.451 $ 1.213 
Denali Therapeutics Inc   33.98 %$ 1.987 $ 5.847 
Neurocrine Biosciences Inc   32.74 %$ 99.000 $ 302.400 
Repligen Corp  32.27 %$ 28.227 $ 87.462 
Neogen Corp  27.67 %$ 30.184 $ 109.074 
Reynolds Consumer Products Inc   22.99 %$ 189.000 $ 822.000 
Fulgent Genetics Inc   18.47 %$ 3.189 $ 17.265 
Assembly Biosciences inc   17.02 %$ 6.701 $ 39.376 
Acorda Therapeutics inc   15.72 %$ 5.285 $ 33.618 
Abbvie Inc   14.16 %$ 1,476.000 $ 10,425.000 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

URBN's Profile

Stock Price

URBN's Financials

Business Description

Fundamentals

Charts & Quotes

URBN's News

Suppliers

URBN's Competitors

Customers & Markets

Economic Indicators

URBN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright Š 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071